Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Corvus Pharmaceuticals

Corvus Pharmaceuticals
2014 FOUNDED
PUBLIC STATUS
41-50 EMPLOYEES
CRVS STOCK SYMBOL
$3.83 SHARE PRICE (As of Wednesday Closing)
Description

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on developing and commercializing small molecule and antibody agents that target the immune system to treat patients with cancer.

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • 863 Mitten Road
  • Suite 102
  • Burlingame, CA 94010
  • United States

+1 (650) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Corvus Pharmaceuticals’s full profile, request a free trial.

Corvus Pharmaceuticals Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$2.53 - $8.10 $118M $3.96 -$1.57 144K 30.9M

Corvus Pharmaceuticals Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value (4,795) (15,174) 118,287 153,918
Revenue 0 0 0 0
EBITDA (47,847) (48,375) (55,682) (36,382)
Net Income (46,134) (46,939) (55,663) (36,375)
Total Assets 92,470 118,232 94,775 140,150
Total Debt 3,387 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Corvus Pharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Corvus Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Corvus Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is reserved for PitchBook Platform users. To explore Corvus Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook
To view this company’s complete Cap Table, request access »

Corvus Pharmaceuticals Competitors (36)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Inovio Pharmaceuticals Corporation PA 000 000.00 0000000000 000.00
00000000000 Angel-Backed Culver City, CA 00000 000000000000 00000
000000000 Venture Capital-Backed Rockville, MD 000.00 0000000000 0 000.00
00000 00000000000 Formerly VC-backed Hayward, CA 000 00000 000000 - 000 00000
000000 00000000000 Corporation Cambridge, MA 000 00000 000000 - 000 00000
To view this company’s complete list of competitors, request access »

Corvus Pharmaceuticals Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Corvus Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Corvus Pharmaceuticals Executive Team (10)

Name Title Board
Seat
Contact
Info
Richard Miller MD Chief Executive Officer & Chairman
Leiv Lea Chief Financial Officer & Chief Accounting Officer
Joseph Buggy Ph.D Founder & Executive Vice President
William Jones Ph.D Senior Vice President
Erik Verner Ph.D Vice President

3 Former Executives

You’re viewing 5 of 10 executives. Get the full list »

Corvus Pharmaceuticals Board Members (8)

Name Representing Role Since Contact
Info
Linda Grais MD Self Board Member 000 0000
Peter Thompson MD Self Co-Founder & Board Member 000 0000
Richard Miller MD Corvus Pharmaceuticals Chief Executive Officer & Chairman 000 0000
Scott Morrison Corvus Pharmaceuticals Board Member 000 0000
Steve Krognes Self Board Member 000 0000

2 Former Board Members

You’re viewing 5 of 8 board members. Get the full list »